rais price target follow solid mark decent
activ rais full year guidanc invest care coordination/
home treatment improv posit world move toward valu base
care remain bullish improv capit effici hold rate
unchang encourag underli trend applaud focu
fcf/better capit effici rais estim increas
price target adj ep vs prior
revenu came ahead estim better
expect natx growth vs strhe contribut
calcimimet off-set lower revenu per treatment
vs strhe strong top line coupl ebit margin
bp better think vs strhe tie
calcimimet benefit oi underli oper perform roughli
in-lin on-going labor product pharma cost improv epo
drive adjust ebit vs strhe beat
amplifi lower tax rate share count vs strhe
result adjust ep comfort ahead estim
manag also rais full year guidanc adjust oper incom
 oper cash flow
care coordin dialysi patient announc launch
nehphrolog allianc program allow nephrologist come
togeth util predict analyt patient educ clinic
expertis deepen care coordin slow kidney progress facilit
earli treatment pd hhd seen strong earli interest
nephrologist join physician play integr role
propos cmmi model shift toward valu on-going would expect
interest remain high compani also dial increment cost
expect tie advocaci cost potenti re-introduct
proposit elect
posit adjust oi intern goodwil write-down
intern busi post adjust oper incom inclus
fx benefit result includ goodwil impair charg
kidney care health oper tie compani german
oper manag continu expect posit adjust oper
incom ex fx goodwil adjust full year expect
tr target
ebitda adjust nci equiti incom
focu segment remain build scale continu like diversif
intern busi see plenti increment growth potenti expect becom
meaning piec total busi time
encourag guidanc rais flow trend robust cffo
come well ahead estim strhe dso improv
day day addit compani rais full year cffo guidanc
 lower capital-expenditure expect tie moder de novo
spend delay sever develop project share buy-back activ remain robust
repurchas tender addit sinc quarter end final
manag rais full year adjust ep guidanc midpoint rang
 increas larg driven lower share count despit inclus expect cost
associ ca ballot initi prior guidanc rais full year
adjust ep estim reflect aggress
share buy-back assumptions/upd guidanc maintain hold rate rais target
ep
page
revenu
revenu
revenu
revenu
revenu
amort net tax
page
base denver co davita inc lead provid dialysi servic unit state
intern patient suffer chronic kidney failur end stage renal diseas esrd
recent sale davita medic group optum allow debt repay share
repurchas on-going capit deploy activ
continu like core dialysi busi acknowledg potenti opportun tie
integr care longer term view near term fundament mix enthusiasm
expect improv capit effici somewhat off-set industri pressur labor ballot
initi slow organ volum trend rate share hold
valuat risk
price target base trade adjust ep slight discount industri
peer freseniu medic fm view appropri given less product geograph
diversif recent sluggish organ volum trend
risk rate price target upsid risk includ better expect reimburs
oper perform downsid risk includ wors expect reimburs pressur
slow organ trend
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
